Farma Hub Overseas Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 07-11-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.40 Cr
as on 07-11-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 421.69%
(FY 2023)
About Farma Hub Overseas
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹6.40 Cr.
Ashish Virmani, Shiv Agrawal, and Mansi Virmani serve as directors at the Company.
- CIN/LLPIN
U24299UR2021PTC011972
- Company No.
011972
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Farma Hub Overseas?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shiv Agrawal  | Additional Director | 20-Feb-2024 | Current |
| Ashish Virmani | Director | 19-Jan-2021 | Current |
| Mansi Virmani | Director | 19-Jan-2021 | Current |
Financial Performance of Farma Hub Overseas.
Farma Hub Overseas Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Farma Hub Overseas?
Unlock access to Farma Hub Overseas's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Wrasse Pharmaceuticals Private LimitedActive 6 years 5 monthsAshish Virmani and Mansi Virmani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Aug 2022 | ₹6.40 Cr | Open |
How Many Employees Work at Farma Hub Overseas?
Farma Hub Overseas has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Farma Hub Overseas, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Farma Hub Overseas's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
